Endpoints News – Biotech, drug, pharma and health news for …
WEBIn biotech's uneven recovery, 50 startups raised megarounds in first half of 2024. 2 months ago.
Endpoints Careers - Find your next biopharma job
WEBNew benefit for Enterprise subscribers. All companies with an Enterprise subscription to Endpoints News will now receive two spotlight job postings per year at no charge.Contact your company subscriptions manager or DeAna ([email protected]) for more information.. For sales inquires or package requests, connect with Meg at [email protected].
Women in Biopharma 2021 | 7 December - 2pm EST | Online Event
WEB2:00 - 3:35pm EST. While a number of biopharma companies have launched efforts to address the sparse number of women in high-ranking positions, there’s still much work to be done. In our 3rd annual Women in Biopharma R&D report, Endpoints News continues its celebration of women who are blazing trails in drug research and leaving lasting marks ...
AI startup Entos looks to one-up the rest of the field by folding ...
WEBJul 14, 2021 · AI startup Entos looks to one-up the rest of the field by folding quantum mechanics into its discovery platform
Big dreams dominate among next-gen biotech players
WEBHere’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or go down fighting for a landmark change. This marks Carroll’s 20th year selecting top private biotechs for special recognition. Join us at this special event in Boston to recognize this year’s group. sponsored by. see the winners.
Endpoints at #JPM24 | Primed to unlock biopharma's next …
WEBThe Endpoints Hub will be open for coworking & networking — power up your devices, check email and grab coffee and a bite between session. On Tuesday, you’ll go to biotech downturn survival school, hear about the data private investors expect to see in a tricky capital market and find out the future plans for pharma from top execs in the ...
Endpoints at #JPM22 - A look at what's to come in 2022
WEBEndpoints has been there to chronicle it with wall-to-wall coverage, and our founder and editor John Carroll has convened top newsmakers to provide detailed insights about their strategies. For #JPM22, Endpoints is expanding on our proud tradition with multiple panels addressing the most important issues in biopharma R&D. title sponsor.
News – Endpoints News
WEBSanofi, Regeneron to refile Dupixent for skin condition after new study win. 17 hours ago. R&D. FDA+.
Endpoints News – The biopharma world is here
WEBEndpoints News – The biopharma world is here. Get the latest reports on drug development, clinical trials, deals and more from the industry experts.
Changing the paradigm for colorectal cancer: Clinical practice
WEBMany ongoing studies aim to improve treatment and outcomes for early-stage colorectal cancer, including guiding adjuvant chemotherapy decisions and bringing targeted therapies and immunotherapies into the early-stage setting. Join us for a webinar and panel discussion on the ways in which the paradigm for colorectal cancer care …